Activity Preview


HEARTLIGHT: Endoscopically Guided Laser Balloon Ablation for the Treatment of Atrial Fibrillation: Insights, Outcomes and the Future

Activity Type:

  • On-Demand

This activity has expired

Release Date: 5/31/2017

Expiration Date: 5/31/2018

  • Participation - no CE credit: 0



Insights, outcomes and the future of the HeartLight Endoscopically Guided Laser Balloon Ablation Catheter. The HeartLight® Endoscopic Ablation System is indicated for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation. Federal Law (USA) restricts this device to sale by or on the order of physician.

As presented at HR2017 Rhythm Theater Session:


Vivek Reddy, MD Professor of Medicine, Mount Sinai School of Medicine, New York, NY

Douglas Packer, MD, FHRS Professor of Medicine, Mayo Clinic, Rochester, MN

Srinivas Dukkipati, MD, Professor of Medicine, Mount Sinai School of Medicine, New York, NY

Andreas Metzner, MD, Department of Cardiology, St. Georg Hospital, Hamburg, DE

Andrea Natale, MD, FACC, FHRS, FESC Executive Medical Director, Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, Austin, TX

Mike Mangrum, MD Associate Professor of Medicine, University of Virginia, Charlottesville, VA

Matthew Reynolds, MD, M.Sc. Baim Institute for Clinical Research and Lahey Hospital, Burlington, MA

Petr Neuzil, MD, PhD Professor of Medicine, Na Homolce Hospital, Prague, CZ


Catheter Ablation

Major Topic Area(s)

Atrial Fibrillation

Atrial Flutter

Clinical Research